Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 ⁺ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Autor: Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France.; CRCI2NA, INSERM UMR 1307 & CNRS UMR 6075, IRS_UN, University of Nantes, Nantes, France., Leguay T; Hematology Department, CHU Hôpital Haut-Lévèque, Pessac, France., Delord M; Department of Population Health Sciences, School of Life Course & Population Sciences, King's College London, London, United Kingdom., Salek C; Institute of Hematology and Blood Transfusion and Charles University, First Faculty of Medicine, Prague, Czech Republic., Kim R; Service d'Hématologie Biologique, Hôpital Saint-Louis-Université Paris Cité, INSERM/CNRS U944/UMR7212, Paris, France., Huguet F; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, France., Hicheri Y; Hematology Department, Institut Paoli-Calmettes, Marseille, France., Wartiovaara-Kautto U; Hematology Department, Helsinki University Hospital, Helsinki, Finland., Raffoux E; Hematology Department, Hôpital St-Louis, APHP, Paris, France., Cluzeau T; Hematology Department, Hôpital Archet CHU Nice, Nice, France., Balsat M; Hematology Department, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre Bénite, France., Roth-Guepin G; Hematology Department, CHU de Nancy, Nancy, France., Tavernier E; Hematology Department, CHU de St-Etienne, Saint-Priest-en-Jarez, France., Lepretre S; Hematology Department, Centre Henri Becquerel, Rouen, France., Bilger K; Hematology Department, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Bergugnat H; Service d'Hématologie Biologique, Hôpital Saint-Louis-Université Paris Cité, INSERM/CNRS U944/UMR7212, Paris, France., Berceanu A; Hematology Department, CHU Jean Minjoz, Besançon, France., Alexis M; Hematology Department, CHR d'Orleans, Orleans, France., Doubek M; Hematology Department, Fakulni Nemocnice Brno, Brno, Czech Republic., Brissot E; Sorbonne University, Hematology Department, Saint-Antoine Hospital, INSERM UMR 938, Paris, France., Hunault-Berger M; Hematology Department, CHU d'Angers, Angers, France., Lebon D; Hematology Department, CHU Amiens Sud, Amiens, France., Turlure P; Hematology Department, CHU de Limoges, Limoges, France., Chantepie S; Hematology Department, CHU de Caen, Caen, France., Belhabri A; Hematology Department, Centre Lyon Bérard, Lyon, France., Wickenhauser S; Hematology Department, CHU de Nîmes, Nîmes, France., Bastie JN; Hematology Department, CHU de Dijon, Dijon, France., Cacheux V; Hematology Department, CHU de Clermont-Ferrand, Clermont-Ferrand, France., Himberlin C; Hematology Department, CHU de Reims, Reims, France., Banos A; Hematology Department, CHR de la Côte Basque, Bayonne, France., Gardin C; Hematology Department, Hôpital Avicenne, APHP, Paris, France., Bonnet S; Hematology Department, Hôpital St-Eloi CHU, Montpellier, France., Plantier I; Hematology Department, Hôpital Victor Provo, Roubaix, France., Pica GM; Hematology Department, CHR Métropole Savoie, Chambéry, France., Escoffre-Barbe M; Hematology Department, Hôpital Pontchaillou CHU, Rennes, France., Boissel N; Hematology Department, Unité Adolescent et Jeunes Adultes, Préservation de la Fertilité, Hôpital St-Louis, APHP, Paris & EA-3518, Institut Universitaire d'Hématologie, Université Paris-VII, Paris, France., Dombret H; Institut de Recherche Saint-Louis (IRSL), Centres de Recherches, Paris & Département de l'UFR de Médecine de l'Université Paris Diderot-Paris 7, Paris, France., Clappier E; Service d'Hématologie Biologique, Hôpital Saint-Louis-Université Paris Cité, INSERM/CNRS U944/UMR7212, Paris, France., Rousselot P; Division of Hematology, Centre Hospitalier de Versailles, Université Versailles Paris-Saclay, Le Chesnay, France.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec 20; Vol. 42 (36), pp. 4327-4341. Date of Electronic Publication: 2024 Oct 17.

Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia.

Autor: Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wierzbowska A; Department of Hematology, Medical University of Lodz, Lodz, Poland., Cluzeau T; Department of Hematology, Centre Hospitalier Universitaire de Nice (CHU), Cote d'Azur University, Nice, France., Laribi K; Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France., Recher C; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse 3 Paul Sabatier, Toulouse, France., Czyz J; Hematology, Szpital Uniwersytecki nr 2, Dr Jana Biziela, Kujawsko-pomorskie, Bydgoszcz, Poland.; Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland., Ochrem B; Department of Hematology, University Hospital, Kraków, Poland., Ades L; Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Gallego-Hernanz MP; Department of Hematology, CHU La Miletrie, Poitiers, France., Heiblig M; Service d'Hématologie Clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France., Audisio E; Haematology Department, S.C. Ematologia 2, Torino, Italy., Zarzycka E; Department of Hematology and Transplantation, Medical University of Gdańsk, Gdańsk, Poland., Li S; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA., Ferenc N; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA., Yeh T; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA., Faller DV; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA., Sedarati F; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Nov 28, pp. 1-11. Date of Electronic Publication: 2024 Nov 28.

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

Autor: Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy., Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Santini V; University of Florence, Florence, Italy., Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Singh A; Cleveland Clinic, Cleveland, OH, USA., Jain AG; Cleveland Clinic, Cleveland, OH, USA., Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA., Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA., Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Bennett JM; University of Rochester Medical Center, Rochester, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bejar R; University of California San Diego, San Diego, CA, USA., Carraway HE; Cleveland Clinic, Cleveland, OH, USA., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA., Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., List AF; Precision BioSciences, Durham, NC, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA., Stahl M; Dana Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Steensma DP; Ajax Therapeutics, Cambridge, MA, USA., Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy., Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sanz G; Instituto de Salud Carlos III, Valencia, Spain., Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain., Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozman M; Hospital Clínic Barcelona, Barcelona, Spain., Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Foucar MK; University of New Mexico, Albuquerque, NM, USA., Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil., Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK., Cluzeau T; Nice University Hospital, Nice, France., Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands., Ades L; Saint Louis Hospital, Paris Cité University, Paris, France., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e862-e872. Date of Electronic Publication: 2024 Oct 09.

[Nurturing and growing a community of department heads: Act 2 in haematology].

Autor: Houot R; Service d'hématologie clinique, CHU de Rennes, Rennes, France. Electronic address: roch.houot@chu-rennes.fr., Calmettes C; Service d'hématologie et d'oncologie, centre hospitalier de Périgueux, Périgueux, France., Park S; Service d'hématologie, CHU Grenoble-Alpes, Grenoble, France., Pascal L; Service d'oncohématologie, hôpital Saint-Vincent-de-Paul, groupement des hôpitaux de l'Institut Catholique de Lille, Lille, France., Peffault de Latour R; Service d'hématologie greffe, hôpital Saint-Louis, Paris, France., Pigneux A; Service d'hématologie clinique et de thérapie cellulaire, CHU de Bordeaux, Bordeaux, France., Quinquenel A; Service d'hématologie clinique, CHU de Reims, Reims, France., Raffoux E; Service d'hématologie adultes, hôpital Saint-Louis, AP-HP, université Paris Cité, Paris, France., Thieblemont C; Hémato-oncologie, hôpital Saint-Louis, Assistance publique-Hôpitaux de Paris, université de Paris Cité, Paris, France., Touati M; Service d'hématologie clinique et thérapie cellulaire, CHU Dupuytren, Limoges, France., Trebouet A; Médecine hématologie, CH Bretagne Sud, Lorient, France., Vaida I; Service d'hématologie et thérapie cellulaire, hôpital NOVO, Pontoise, France., Wémeau M; Service d'hématologie, centre hospitalier de Roubaix, Roubaix, France., Bastie JN; Hématologie clinique, CHU de Dijon Bourgogne François-Mitterrand, Dijon, France., Bay JO; Service de thérapie cellulaire et d'hématologie clinique adulte, CHU de Clermont-Ferrand, Clermont-Ferrand, France., Cluzeau T; Service d'hématologie et maladies du sang, CHU de Nice, Nice, France., Cornillon J; Service d'hématologie clinique et de thérapie cellulaire, CHU de Saint-Étienne, Saint-Étienne, France., Damaj G; Institut d'hématologie, CHU de Caen, Caen, France., Deconinck E; EFS, Inserm, UMR RIGHT, CHU de Besançon, université de Franche-Comté, 25000 Besançon, France., Feugier P; Service d'hématologie adulte, CHRU Nancy, Vandœuvre-Lès-Nancy, France., Fornecker LM; Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, France., Gay J; Service d'hématologie, CHIC Côte Basque, Bayonne, France., Hermine O; Service d'hématologie clinique, hôpital Necker, AP-HP, Paris, France., Hospital MA; Service d'hématologie, institut Paoli-Calmettes, Marseille, France., Hunault M; Service des maladies du sang, CHU d'Angers, Angers, France., Jaccard A; Service d'hématologie clinique et thérapie cellulaire, CHU Dupuytren, Limoges, France., Jardin F; Service d'hématologie, centre Henri-Becquerel, Rouen, France., Le Calloch R; Service d'hématologie, CHIC Cornouaille, Quimper, France., Legros L; Service d'hématologie clinique, AP-HP, université Paris-Saclay, Le Kremlin-Bicêtre, France., Leleu X; Service d'hématologie clinique et de thérapie cellulaire, CHU La Milétrie, Poitiers, France., Lemonnier F; Unité hémopathies lymphoïdes, groupe hospitalier Henri-Mondor, AP-HP, Créteil, France., Malfuson JV; Service d'hématologie, HIA Percy, Clamart, France., Morel P; Service d'hématologie clinique et thérapie cellulaire, CHU Amiens-Picardie, Amiens, France., Ochmann M; Service d'hématologie, CHU d'Orléans, Orléans, France., Orsini-Piocelle F; Service d'hématologie, centre hospitalier Annecy-Genevois, Annecy, France., Gyan E; Service d'hématologie et thérapie cellulaire, CHU de Tours, Tours, France.

Publikováno v: Bulletin du cancer [Bull Cancer] 2024 Oct; Vol. 111 (10), pp. 980-986. Date of Electronic Publication: 2024 Sep 11.

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial.

Autor: Della Porta MG; Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.edu., Garcia-Manero G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Santini V; MDS Unit, Hematology, University of Florence, DMSC, AOUC, Florence, Italy., Zeidan AM; Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT, USA., Komrokji RS; Moffitt Cancer Center, Tampa, FL, USA., Shortt J; Monash University and Monash Health, Melbourne, VIC, Australia., Valcárcel D; Vall Hebron Institute of Oncology (VHIO), Hematology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Jonasova A; Medical Department, Hematology, Charles University General Hospital, Prague, Czech Republic., Dimicoli-Salazar S; Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Tiong IS; Malignant Haematology & Stem Cell Transplantation, The Alfred, Melbourne, VIC, Australia; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Lin CC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Li J; Bristol Myers Squibb, Princeton, NJ, USA., Zhang J; Bristol Myers Squibb, Princeton, NJ, USA., Pilot R; Bristol Myers Squibb, Princeton, NJ, USA., Kreitz S; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland., Pozharskaya V; Bristol Myers Squibb, Princeton, NJ, USA., Keeperman KL; Bristol Myers Squibb, Princeton, NJ, USA., Rose S; Bristol Myers Squibb, Princeton, NJ, USA., Prebet T; Bristol Myers Squibb, Princeton, NJ, USA., Lai Y; Bristol Myers Squibb, Princeton, NJ, USA., Degulys A; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Paolini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Cluzeau T; Département d'Hématologie Clinique, Université Cote d'Azur, CHU Nice, Nice, France., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France., Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2024 Sep; Vol. 11 (9), pp. e646-e658. Date of Electronic Publication: 2024 Jul 19.